Today: 27 January 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Xbox’s New Handheld Costs $1,000 – Why the ROG Ally X Has Gamers Talking

Xbox’s New Handheld Costs $1,000 – Why the ROG Ally X Has Gamers Talking

Xbox Joins the Handheld Gaming Race For the first time, Microsoft is officially putting the “Xbox” name on a handheld gaming device. In partnership with Asus’ Republic of Gamers division, Microsoft announced the ROG Xbox Ally and ROG Xbox Ally X – two portable gaming PCs that integrate tightly with the Xbox ecosystem. Unlike a traditional console, these devices are…
26 September 2025
·
Trump’s Tariff Tsunami: 100% Drug Tax and New Import Levies Rock Global Trade

Trump’s Tariff Tsunami: 100% Drug Tax and New Import Levies Rock Global Trade

Trump’s New Tariff Salvo: Drugs, Trucks and Cabinets Under Fire In a dramatic escalation of his trade war, President Donald Trump on Thursday unveiled a new wave of tariffs targeting pharmaceuticals, trucks, and home furnishings. In a Truth Social post on September 25, Trump announced the U.S. will impose a 100% import tariff on any branded or patented pharmaceutical products…
26 September 2025
·
Breeze Airways Goes International – $99 Flights to Caribbean Hotspots Unveiled

Breeze Airways Goes International – $99 Flights to Caribbean Hotspots Unveiled

New Routes to Mexico and the Caribbean Breeze Airways has pulled the curtain off its long-awaited international debut, unveiling a slate of new flights to popular beach destinations in Mexico and the Caribbean. In total, the airline announced seven nonstop routes that will launch in early 2026 – marking the first time Breeze ventures beyond U.S. borders Thepointsguy. The destinations…
26 September 2025
·
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Stock Price and Recent Performance Pfizer’s stock has struggled in 2025, hovering near multi-year lows. At ~$23.60 per share in late September, PFE has declined about 9% since January, underperforming the S&P 500 (which is up modestly) and lagging the broader healthcare sector. Over the past 12 months, the stock is down roughly 18%. The 52-week high was $30.43, and…
26 September 2025
·····
SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

Key facts (Sept 25–26, 2025): In‑depth report 1) What actually moved SNAP during Sept 25–26 Snap’s 1.34% gain to $8.33 on Sept 25 stood out in a weak tape, with ~247M shares trading (well above recent norms). The session left SNAP still well below its 52‑week peak ($13.28), but the resilience contrasts with declines across mega‑cap peers that day. That divergence sets up a…
26 September 2025
···
RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

Key facts (Sept. 25–26, 2025) What just happened—and why it mattered Timeline (Sept. 24–26): Strategic aim: Management is steering fresh equity toward debt reduction, specifically highlighting the 8.00% notes due 2027. If all base proceeds went against those notes, annual interest expense could fall by ~$30.5M (and ~$35M with a fully exercised green‑shoe), before fees and taxes. The greenshoe option…
26 September 2025
····
PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

Key facts (Sept. 25–26, 2025): What changed for PLUG on Sept. 25–26 A price‑target ceiling moved up. Craig‑Hallum raised its PLUG price target to $4, the highest on the Street, keeping a Buy stance. For a stock that closed Sept. 25 at $2.36, that’s a headline‑grabbing reset that can sway short‑term sentiment. Yahoo Finance Validating ops, cautiously on fundamentals. On…
26 September 2025
····
DFLI Pops 11% as Lithium Mania Spills Into Micro‑Caps — What Today’s Pre‑Market Says and the 3 Big Risks (Sept 25–26, 2025)

DFLI Pops 11% as Lithium Mania Spills Into Micro‑Caps — What Today’s Pre‑Market Says and the 3 Big Risks (Sept 25–26, 2025)

What just happened to DFLI (Sept 25–26) Price action: On Thursday (Sept 25), DFLI rallied 11.4% to $0.3781, swinging nearly 30% intraday ($0.300–$0.3899) on 21.66M shares — well above the recent average. Early Friday (Sept 26) pre‑market indications hovered near $0.40 after an initial print at $0.45, signaling lingering speculative interest into the open. Investing Catalyst mix: There was no…
26 September 2025
···
DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

Key facts (Sept. 25–26, 2025) In‑depth report What happened, and why it matters Datavault AI — the former WiSA Technologies that rebranded in February 2025 — secured a headline‑grabbing $150 million commitment from Scilex, delivered in Bitcoin. The company frames the deal as jet fuel for AI‑driven data monetization, saying the capital will build out a supercomputer footprint and launch…
26 September 2025
····
AMPY Just Popped ~22% in a Day — Is Amplify Energy’s Rally For Real or a Head‑Fake? What the Fresh Data (Sept. 25–26) Really Shows

AMPY Just Popped ~22% in a Day — Is Amplify Energy’s Rally For Real or a Head‑Fake? What the Fresh Data (Sept. 25–26) Really Shows

In‑depth report What actually happened on Sept. 25–26 Price action: AMPY finished Sept. 25 at $5.84 (+21.67%), trading in a wide $5.17–$6.22 intraday range and posting ~13.5M shares in volume (vs. prior day ~0.54M). The step‑function move capped a three‑session upswing from $4.63 on Sept. 23. StockAnalysis Fresh discourse on Sept. 26: Before the market opened on Sept. 26, a…
26 September 2025
····
SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

Key facts (Sept. 25–26, 2025) What happened — and why it matters SciSparc’s new program aims to apply quantum algorithms to hard problems in protein folding and protein–ligand interactions, with the goal of more precise simulations that speed discovery in neurological and rare diseases. The board authorized creating a wholly‑owned Israeli subsidiary to run the effort and to pursue IP around…
26 September 2025
····
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

Key facts (25–26 Sept 2025) What happened—and why it mattered UnitedHealthcare coverage win. On Sept. 25, Plus Therapeutics announced that UnitedHealthcare Insurance Company (UNH) granted national coverage for its CNSide® CSF Tumor Cell Enumeration LDT for metastatic CNS cancer, effective Sept. 15. The deal potentially opens access to more than 51 million members nationwide and positions CNSide as a covered…
26 September 2025
···
1 … 446 447 448 449 450 … 584

Stock Market Today

  • Hilton Food Group Eyes 48% Upside Amid Mixed Financial Signals
    January 27, 2026, 2:31 AM EST. Hilton Food Group (HFG.L) shows a potential 48.26% upside, driven by 7.6% revenue growth and a 6.78% dividend yield. Trading at 516 GBp, near its 52-week low, the company faces a high forward P/E of 937.09, signaling growth expectations or possible overvaluation. Its 12.89% ROE indicates efficient profit generation, yet a negative free cash flow of £30.28 million hints at liquidity pressures. Analyst sentiment remains positive with no sells and an average price target of 765 GBp. Technical indicators show mixed signals, with the stock above its 50-day moving average but below the 200-day. Investors should weigh strategic international expansion against short-term financial challenges in this Consumer Defensive sector player.
Go toTop